The largest database of trusted experimental protocols

Zorbax sb c8

Manufactured by Agilent Technologies
Sourced in United States, Germany

The Zorbax SB-C8 is a reversed-phase high-performance liquid chromatography (HPLC) column designed for the separation and analysis of a wide range of organic compounds. It features a silica-based stationary phase with n-octyl (C8) functional groups, providing moderate hydrophobicity for the retention of moderately polar to non-polar analytes.

Automatically generated - may contain errors

22 protocols using zorbax sb c8

1

Deuterium-Labeled Peptide Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
[D4]L-alanine from Cambridge Isotope Laboratories (Tewksbury, MA) was modified with an N-terminal Fmoc protecting group and was recrystallized from Ethyl acetate/hexane (80:20). Other protected amino acids and Rink amide resin, including arginine whose side chain was additionally protected with 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl (Pbf) protecting group, were purchased from Anaspec (Freemont, CA), Bachem (Torrance, CA), Sigma Aldrich and NovaBiochem (MillaporeSigma, Burlington, MA). Peptides were synthesized on a model 433A solid-phase peptide synthesizer (Applied Biosystems/Thermo Fisher Sci.; Foster City, CA) using a 0.1 mmol scale FastMoc chemistry. Two deuterium-labeled alanines were incorporated per peptide, with 50% and 100% isotope abundance levels, to distinguish the 2H NMR signals based on relative intensities. Following cleavage from the resin using a trifluoroacetic acid (TFA) based cocktail, the resulting C-termini amidated peptides were precipitated with methyl-tert-butyl-ether/hexane (50:50). The peptides were purified by reversed-phase high-performance liquid chromatography on a 5 μm octylsilica Zorbax SB-C8 or SB300-C3 column (9.4 mm × 250 mm) (Agilent Technologies, Santa Clara, CA), as described in [32 (link), 49 (link)]. The molecular mass of peptide and distributions of deuterium were confirmed by MALDI-TOF mass spectrometry (Figure S1).
+ Open protocol
+ Expand
2

Stability Assessment of Compounds 1-4

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aliquots of 14 (0.1 mg) were dissolved in either 0.1% TFA in MeCN (0.5 mL) or 0.1% TFA in MeOH (0.5 mL) and heated at 40 °C for 24 h, after which the solutions were analysed by HPLC-DAD-MS (Agilent Zorbax SB-C8, 5 μm, 4.6 × 150 mm column, 15 min gradient elution at 1 mL min−1 from 90% H2O–MeCN to 100% MeCN with isocratic 0.05% formic acid modifier). Samples of 14 (0.1 mg) dissolved in MeOH (1.0 mL) were used as authentic standards, and analysed by the same HPLC method. Analytical results, as illustrated in the ESI Fig. S12–S14, demonstrate that whereas 1 and 4 were stable under these conditions, 2 and 3 equilibrate, and transform through 5 and 6, to 7 and 8, and finally to 4.
+ Open protocol
+ Expand
3

Quantification of Ceramides and Diacylglycerols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ceramides and diacylglycerols (DAG) were measured according to the methods as previously described [43 (link),44 (link)]. Briefly, lipids were extracted from ~20mg of tissue using an extraction mixture consisting of isopropanol:water:ethyl acetate (35:5:60; v:v:v). The ceramides and DAG were measured using an Agilent 6460 triple quadrupole mass spectrometer. Both sphingolipids and DAG were analyzed using a positive ion electrospray ionization source with multiple reaction monitoring. Chromatographic separation was performed using an Agilent 1290 Infinity Ultra Performance Liquid Chromatograph. The analytical column was a reverse-phase Zorbax SB-C8, 2.1x150 mm, 1.8 μm (Agilent, USA). The separation was conducted in a binary gradient using 2 mM ammonium formate, 0.15% formic acid in methanol as Solvent A and 1.5 mM ammonium formate, 0.1% formic acid in water as Solvent B at a flow rate of 0.4 ml/min. C17:0-ceramide and 1,3-dipentadecanoyl-rac-glycerol (Avanti Polar Lipids, USA) were used as the internal standards.
+ Open protocol
+ Expand
4

Isolation and Purification of MDN-0066 from Fermentation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 3L fermentation was acidified to pH 3 with HCl 6N. The acidified fermentation was extracted with methylethylketone (MEK, 3L) under shaking at 220 rpm for 1 h. The aqueous phase was then separated by centrifugation and discarded, and the organic phase (ca. 3L) was concentrated to dryness on a rotary evaporator. The dried extract was fractionated by reversed-phase preparative HPLC (Agilent Zorbax SB-C8, 21.2 x 250 mm, 7 μm; 20 mL/min, UV detection at 210 nm, gradient H2O + 0.1%TFA:CH3CN + 0.1%TFA from 5% to 100% organic in 40 minutes) yielding a fraction eluting at 29.5 min that was further purified by semipreparative HPLC (Agilent Zorbax RX-C8, 9.4 x 250 mm, 5μm; 3.6 mL/min, UV detection at 210 nm, gradient H2O + 0.1%TFA:CH3CN + 0.1%TFA from 75% to 80% acetonitrile in 40 minutes) to yield 52.8 mg of MDN-0066 as a white amorphous solid. All fractionation steps were guided by testing of inhibitory activity in the RCC4-VA/VHL assays.
+ Open protocol
+ Expand
5

Quantification of Serum S1P in Atrial Fibrillation

Check if the same lab product or an alternative is used in the 5 most similar protocols
S1P was measured in serum of 141 AF patients whereas 21 had FU samples and data accessible. S1P was determined by LC-MS/MS as previously described [24 (link)]. In brief, 20 µL of serum sample were incubated with 20 µL of internal standard 1 µM [16,17,18-2H7]-S1P (S1P-d7, Avanti Polar Lipids, Alabaster, AL, USA) and subsequently proteins were precipitated by addition of 350 µL of acetonitrile/water, 80/20 (vol/vol). The supernatant was subjected to reverse-phase chromatography on a Zorbax SB-C8 (2.1 × 50 mm; Agilent Technologies, Santa Clara, CA, USA). S1P was eluted with 0.35 ml/min as a binary gradient for 6 min (methanol/acetonitrile/0.1% formic acid: 2.5/2.5/95–30/30/40, vol/vol/vol) and quantified by tandem mass spectrometry (Varian L1200 MS/MS, Agilent Technologies, Waldbronn, Germany).
+ Open protocol
+ Expand
6

Multimodal Instrumental Analysis of Analytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analytes were extracted and analyzed from the matrix samples using the following equipment: ultrasonic unit Elmasonic S30 (Elma-Hans Schmidbauer GmbH, Germany), rotatory shaker Heidolph (Heidolph instruments GmbH, Germany), laboratory centrifuge Eppendorf miniSpin plus (Eppendorf, Germany), chromatography columns Agilent Zorbax SB-C8 150 mm × 4.6 mm × 1.8 μm, Zorbax SB-C18 150 mm × 4.6 mm × 1, 8 μm, and Zorbax SB-C18 250 mm × 4.6 mm × 1.8 μm. Extracts’ concentration was performed using an FMS Super Vap 24 sample preparation system (FMS Inc., USA). The analysis of the sample extracts was conducted with Dionex UltiMate 3000 (Thermo Scientific) with Q Exactive detector (Thermo Scientific) with electrospray ionization (ESI) and liquid chromatograph, LC-20, equipped with an autosampler and mass-selective detector LCMS-8050 with electrospray ionization at atmospheric pressure, (Shimadzu, Japan).
+ Open protocol
+ Expand
7

Liquid Chromatographic Analysis of Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The liquid chromatographic system was an Accela LC (Thermo Scientific, Bremen, Germany) equipped with degasser, Accela 1250 pump, autosampler thermostated at 10°C and a heated column compartment. The column employed was a Zorbax SB-C8, 2.1 x 50 mm and 1.8 µm particle size from Agilent Technologies (Böblingen, Germany) thermostated at 25°C. The mobile phases were 1 mM NH4OAc/0.01% FA in water (A) and 0.01% FA in acetonitrile (B). The gradient program was as follows: 100% A for 0.5 min, then decreased linearly to 20% in 7.0 min, and finally decreased linearly to 0% in 0.5 min and held at 0% for 1.5 min followed by an increase to the initial concentration of 100% A in 0.1 min. Equilibrium time was 2.4 min resulting in a total run time of 12 min. The flow rate was set constant at 250 µL · min−1 and the injection volume was 20 µL.
+ Open protocol
+ Expand
8

HPLC Analysis of Organic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study used Agilent ZORBAX SB-C8 (4.6 mm × 250 mm, 5 μm) as a separation column with a temperature of 30 °C. Moreover, the flow rate, the injection volume, and the detection wavelength were 1 mL/min, 5 μL, and 278 nm, respectively. The mobile phase was ammonium acetate (0.02 mol/L)-acetonitrile, gradient elution (0–8 min, CH3CN 20%; 10–13 min, CH3CN 28%; 13–14 min, CH3CN 20%).
+ Open protocol
+ Expand
9

Sphingolipid profiling of brown planthopper

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected the newly emerged 1st to 5th instar, female and male BPHs with a fresh mass of approximately 0.15 g per sample. Sphingolipids were extracted according to Bielawski’s method (Bielawski et al., 2009 (link)), and 10 ng of C12-ceramide was added as an internal standard. A 10 μl sample was separated on a reversed-phase analytical column (Agilent ZORBAX sb-C8, 2.1 × 150 mm, 3.5 um) with a flow rate of 0.3 ml/min at 35°C and analyzed with the MS/MS method. Solvent A was 2 mM of NH4AC in 0.1% HCOOH, and solvent B was methanol. The gradient was increased from 1 to 99% of solvent B over 20 min, 99 to 100% in 15 min, and held at 100% for the last 7 min. The total monitor time was set to 42 min. The sphingolipids in BPH with a knockdown of NCER were analyzed. At 0.1 g of fresh weight, BPH ovaries were dissected from 3-day-old females after dsRNA-NCER and dsRNA-GFP injection. The sphingolipids were extracted and quantified as mentioned above in triplicate experiments.
+ Open protocol
+ Expand
10

HPLC Analysis of TTX Impurities

Check if the same lab product or an alternative is used in the 5 most similar protocols
TTX content and impurities were analyzed through HPLC using a method previously reported by Chen et al. with slight modifications [33 ]. In brief, the analysis was performed using post-column derivation HPLC with a C8 column (Agilent ZORBAX SB-C8, 4.6 mm × 250 mm, 5 μm) and a fluorescence detector. The mobile phase was a phosphate buffered solution (PBS) of sodium octane sulfonate (0.3 mL/min) at λ = 365 nmex and λ = 510 nmem. The post-column derivative reagent was sodium hydroxide (4 mol/L) at a flow rate of 0.3 mL/min and the derivative temperature was 110 °C in a 50 μL injection volume.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!